Treatment of small intestinal bacterial overgrowth in Chilean patients with irritable bowel syndrome: A prospective and comparative study
Patients with IBS and SIBO benefit from antibiotic therapy. MZ exhibited the best SIBO eradication rate, but RF demonstrated greater symptomatic improvement and a lower rate of adverse effects.
Authors
- Christian von Mühlenbrock (ORCID: https://orcid.org/0000-0001-5285-1147)
- Glauben Landskron (ORCID: https://orcid.org/0000-0002-7953-6769)
- Ana María Madrid
Institutions
- Universidad de Los Andes, Chile (CL)
- Hospital Clínico de la Universidad de Chile (CL)
Publication Details
- Journal
- Revista de Gastroenterología de México (English Edition)
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.rgmxen.2024.08.003
- Citations
- 3
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 5.43